PharmaChain Shield

Resource Directives

PharmaChain Shield

Securing antibiotic supply chains with blockchain, AI, and IoT to combat counterfeits, stockouts, and misuse in real-time.

Islamabad, Pakistan

PAK

For-profit, including B-Corp or similar models

—

Counterfeit antibiotics, supply chain inefficiencies, and antimicrobial misuse are driving the global AMR crisis, which kills 1.27 million annually (WHO). In low-resource regions like Sub-Saharan Africa, 30-60% of medicines are substandard (WHO), 50% of antibiotics are misprescribed (CDC), and 40% of health facilities face stockouts (Ghana FDA), while 25% of temperature-sensitive drugs spoil in transit (UNICEF). Our solution addresses these challenges by leveraging blockchain to verify drug authenticity (e.g., Nigeria’s 80% reduction in counterfeit seizures), AI to predict demand and flag misuse (e.g., Kenya’s 92% demand accuracy, Bangladesh’s 35% prescription reduction), and IoT to monitor storage and automate restocking (e.g., Rwanda’s 99.9% inventory accuracy). Targeting 500M+ people in African pilot regions, this approach is scalable to the 5B+ globally who lack reliable medicine access, combating AMR while ensuring safe, efficient antibiotic delivery.

Our solution, PharmaChain Shield, is a secure, blockchain-powered system that uses AI, IoT, and smart contracts to protect Antibiotics supply chains from counterfeit drugs, poor storage, and stockouts. Each medicine package is tagged with a unique digital ID (QR code, NFC, or RFID) linked to a blockchain record that verifies its origin, batch number, and expiration. As the medicine moves through the supply chain—from manufacturer to end-user—each handoff is recorded on the blockchain, creating an immutable, tamper-proof history. Smart contracts automate critical processes: for example, they only release payments if temperature sensors confirm safe transport, or if delivery is verified by GPS. IoT devices (like temperature/humidity sensors and RFID tags) continuously monitor storage and inventory conditions. AI-powered analytics predict demand, flag unusual prescription patterns, and send early alerts for stockouts or expiring drugs. The system can work in low-connectivity settings by syncing data offline-first and integrates with existing mobile apps used by health workers for drug authentication. By creating transparency, accountability, and automation, PharmaChain Shield builds trust in medicine supply chains and helps save lives.

Our solution serves patients, healthcare workers, regulators, and antibiotics suppliers in low- and middle-income countries, where weak supply chains and counterfeit drugs are a persistent threat. The primary beneficiaries are patients—particularly in rural or underserved areas—who face significant health risks due to fake or degraded medicines. By ensuring drug authenticity, quality, and availability, our system directly safeguards their health. Healthcare workers and pharmacists, who often lack tools to verify medicines or predict shortages, benefit from real-time data on drug conditions and stock levels. With our solution, they can authenticate medicines instantly, receive alerts on expiring stock, and reorder critical drugs automatically, reducing manual errors and improving service delivery. Regulatory agencies gain visibility across the entire supply chain, enabling them to monitor compliance, detect anomalies, and act swiftly in case of recalls or quality breaches. For antibiotics suppliers, the system reduces theft, fraud, and loss due to spoilage, while building consumer trust through transparency. By creating a connected, tamper-proof, and predictive supply ecosystem, our solution empowers all actors—especially those in resource-limited settings—to make safer, faster, and smarter decisions that protect health and save lives.